Market Analysis and Insights: Global Epigenome Analysis Market
The global Epigenome Analysis market is projected to grow from US$ 897 million in 2024 to US$ 1537.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.4% during the forecast period.
Epigenome analysis has garnered increasing research interest across various fields of biology and medicine. The exploration of epigenetic mechanisms in gene regulation and disease development has driven the demand for advanced epigenome analysis technologies and tools. Technological advancements in epigenome analysis, such as next-generation sequencing (NGS) and high-throughput methods, have significantly improved the efficiency and accuracy of epigenetic studies. These advancements have facilitated large-scale epigenome mapping and analysis. Epigenome analysis has found extensive applications in disease research, including cancer, neurological disorders, and autoimmune diseases. Understanding epigenetic modifications can provide valuable insights into disease mechanisms and potential therapeutic targets.
Report Covers:
This report presents an overview of global market for Epigenome Analysis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Epigenome Analysis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Epigenome Analysis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epigenome Analysis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Epigenome Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Epigenome Analysis revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Cellcentric
Syndax
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Enzo Life Sciences
EpiGentek Group
BioVision
Promega Corporation
GeneTex
Pacific Biosciences of California
Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Epigenome Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenome Analysis companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenome Analysis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenome Analysis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 DNA Methylation Analysis
1.2.3 Analysis of DNA Interactions
1.2.4 Chromatin Accessibility
1.2.5 Conformation Assays
1.3 Market by Application
1.3.1 Global Epigenome Analysis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenome Analysis Market Perspective (2019-2030)
2.2 Global Epigenome Analysis Growth Trends by Region
2.2.1 Epigenome Analysis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epigenome Analysis Historic Market Size by Region (2019-2024)
2.2.3 Epigenome Analysis Forecasted Market Size by Region (2025-2030)
2.3 Epigenome Analysis Market Dynamics
2.3.1 Epigenome Analysis Industry Trends
2.3.2 Epigenome Analysis Market Drivers
2.3.3 Epigenome Analysis Market Challenges
2.3.4 Epigenome Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Epigenome Analysis by Players
3.1.1 Global Epigenome Analysis Revenue by Players (2019-2024)
3.1.2 Global Epigenome Analysis Revenue Market Share by Players (2019-2024)
3.2 Global Epigenome Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Epigenome Analysis, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Epigenome Analysis Market Concentration Ratio
3.4.1 Global Epigenome Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenome Analysis Revenue in 2023
3.5 Global Key Players of Epigenome Analysis Head office and Area Served
3.6 Global Key Players of Epigenome Analysis, Product and Application
3.7 Global Key Players of Epigenome Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenome Analysis Breakdown Data by Type
4.1 Global Epigenome Analysis Historic Market Size by Type (2019-2024)
4.2 Global Epigenome Analysis Forecasted Market Size by Type (2025-2030)
5 Epigenome Analysis Breakdown Data by Application
5.1 Global Epigenome Analysis Historic Market Size by Application (2019-2024)
5.2 Global Epigenome Analysis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epigenome Analysis Market Size (2019-2030)
6.2 North America Epigenome Analysis Market Size by Type
6.2.1 North America Epigenome Analysis Market Size by Type (2019-2024)
6.2.2 North America Epigenome Analysis Market Size by Type (2025-2030)
6.2.3 North America Epigenome Analysis Market Share by Type (2019-2030)
6.3 North America Epigenome Analysis Market Size by Application
6.3.1 North America Epigenome Analysis Market Size by Application (2019-2024)
6.3.2 North America Epigenome Analysis Market Size by Application (2025-2030)
6.3.3 North America Epigenome Analysis Market Share by Application (2019-2030)
6.4 North America Epigenome Analysis Market Size by Country
6.4.1 North America Epigenome Analysis Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Epigenome Analysis Market Size by Country (2019-2024)
6.4.3 North America Epigenome Analysis Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Epigenome Analysis Market Size (2019-2030)
7.2 Europe Epigenome Analysis Market Size by Type
7.2.1 Europe Epigenome Analysis Market Size by Type (2019-2024)
7.2.2 Europe Epigenome Analysis Market Size by Type (2025-2030)
7.2.3 Europe Epigenome Analysis Market Share by Type (2019-2030)
7.3 Europe Epigenome Analysis Market Size by Application
7.3.1 Europe Epigenome Analysis Market Size by Application (2019-2024)
7.3.2 Europe Epigenome Analysis Market Size by Application (2025-2030)
7.3.3 Europe Epigenome Analysis Market Share by Application (2019-2030)
7.4 Europe Epigenome Analysis Market Size by Country
7.4.1 Europe Epigenome Analysis Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Epigenome Analysis Market Size by Country (2019-2024)
7.4.3 Europe Epigenome Analysis Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Epigenome Analysis Market Size (2019-2030)
8.2 China Epigenome Analysis Market Size by Type
8.2.1 China Epigenome Analysis Market Size by Type (2019-2024)
8.2.2 China Epigenome Analysis Market Size by Type (2025-2030)
8.2.3 China Epigenome Analysis Market Share by Type (2019-2030)
8.3 China Epigenome Analysis Market Size by Application
8.3.1 China Epigenome Analysis Market Size by Application (2019-2024)
8.3.2 China Epigenome Analysis Market Size by Application (2025-2030)
8.3.3 China Epigenome Analysis Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Epigenome Analysis Market Size (2019-2030)
9.2 Asia Epigenome Analysis Market Size by Type
9.2.1 Asia Epigenome Analysis Market Size by Type (2019-2024)
9.2.2 Asia Epigenome Analysis Market Size by Type (2025-2030)
9.2.3 Asia Epigenome Analysis Market Share by Type (2019-2030)
9.3 Asia Epigenome Analysis Market Size by Application
9.3.1 Asia Epigenome Analysis Market Size by Application (2019-2024)
9.3.2 Asia Epigenome Analysis Market Size by Application (2025-2030)
9.3.3 Asia Epigenome Analysis Market Share by Application (2019-2030)
9.4 Asia Epigenome Analysis Market Size by Region
9.4.1 Asia Epigenome Analysis Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Epigenome Analysis Market Size by Region (2019-2024)
9.4.3 Asia Epigenome Analysis Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Epigenome Analysis Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Epigenome Analysis Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Epigenome Analysis Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Epigenome Analysis Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Epigenome Analysis Introduction
11.1.4 Illumina Revenue in Epigenome Analysis Business (2019-2024)
11.1.5 Illumina Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Epigenome Analysis Introduction
11.2.4 Merck Revenue in Epigenome Analysis Business (2019-2024)
11.2.5 Merck Recent Developments
11.3 QIAGEN
11.3.1 QIAGEN Company Details
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Epigenome Analysis Introduction
11.3.4 QIAGEN Revenue in Epigenome Analysis Business (2019-2024)
11.3.5 QIAGEN Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Epigenome Analysis Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Epigenome Analysis Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Developments
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Epigenome Analysis Introduction
11.5.4 Eisai Revenue in Epigenome Analysis Business (2019-2024)
11.5.5 Eisai Recent Developments
11.6 Abcam
11.6.1 Abcam Company Details
11.6.2 Abcam Business Overview
11.6.3 Abcam Epigenome Analysis Introduction
11.6.4 Abcam Revenue in Epigenome Analysis Business (2019-2024)
11.6.5 Abcam Recent Developments
11.7 Diagenode
11.7.1 Diagenode Company Details
11.7.2 Diagenode Business Overview
11.7.3 Diagenode Epigenome Analysis Introduction
11.7.4 Diagenode Revenue in Epigenome Analysis Business (2019-2024)
11.7.5 Diagenode Recent Developments
11.8 Active Motif
11.8.1 Active Motif Company Details
11.8.2 Active Motif Business Overview
11.8.3 Active Motif Epigenome Analysis Introduction
11.8.4 Active Motif Revenue in Epigenome Analysis Business (2019-2024)
11.8.5 Active Motif Recent Developments
11.9 Zymo Research Corporation
11.9.1 Zymo Research Corporation Company Details
11.9.2 Zymo Research Corporation Business Overview
11.9.3 Zymo Research Corporation Epigenome Analysis Introduction
11.9.4 Zymo Research Corporation Revenue in Epigenome Analysis Business (2019-2024)
11.9.5 Zymo Research Corporation Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Epigenome Analysis Introduction
11.10.4 Thermo Fisher Scientific Revenue in Epigenome Analysis Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Developments
11.11 Cellcentric
11.11.1 Cellcentric Company Details
11.11.2 Cellcentric Business Overview
11.11.3 Cellcentric Epigenome Analysis Introduction
11.11.4 Cellcentric Revenue in Epigenome Analysis Business (2019-2024)
11.11.5 Cellcentric Recent Developments
11.12 Syndax
11.12.1 Syndax Company Details
11.12.2 Syndax Business Overview
11.12.3 Syndax Epigenome Analysis Introduction
11.12.4 Syndax Revenue in Epigenome Analysis Business (2019-2024)
11.12.5 Syndax Recent Developments
11.13 New England Biolabs
11.13.1 New England Biolabs Company Details
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Epigenome Analysis Introduction
11.13.4 New England Biolabs Revenue in Epigenome Analysis Business (2019-2024)
11.13.5 New England Biolabs Recent Developments
11.14 Epizyme
11.14.1 Epizyme Company Details
11.14.2 Epizyme Business Overview
11.14.3 Epizyme Epigenome Analysis Introduction
11.14.4 Epizyme Revenue in Epigenome Analysis Business (2019-2024)
11.14.5 Epizyme Recent Developments
11.15 Domainex
11.15.1 Domainex Company Details
11.15.2 Domainex Business Overview
11.15.3 Domainex Epigenome Analysis Introduction
11.15.4 Domainex Revenue in Epigenome Analysis Business (2019-2024)
11.15.5 Domainex Recent Developments
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Details
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Epigenome Analysis Introduction
11.16.4 Agilent Technologies Revenue in Epigenome Analysis Business (2019-2024)
11.16.5 Agilent Technologies Recent Developments
11.17 AsisChem
11.17.1 AsisChem Company Details
11.17.2 AsisChem Business Overview
11.17.3 AsisChem Epigenome Analysis Introduction
11.17.4 AsisChem Revenue in Epigenome Analysis Business (2019-2024)
11.17.5 AsisChem Recent Developments
11.18 Enzo Life Sciences
11.18.1 Enzo Life Sciences Company Details
11.18.2 Enzo Life Sciences Business Overview
11.18.3 Enzo Life Sciences Epigenome Analysis Introduction
11.18.4 Enzo Life Sciences Revenue in Epigenome Analysis Business (2019-2024)
11.18.5 Enzo Life Sciences Recent Developments
11.19 EpiGentek Group
11.19.1 EpiGentek Group Company Details
11.19.2 EpiGentek Group Business Overview
11.19.3 EpiGentek Group Epigenome Analysis Introduction
11.19.4 EpiGentek Group Revenue in Epigenome Analysis Business (2019-2024)
11.19.5 EpiGentek Group Recent Developments
11.20 BioVision
11.20.1 BioVision Company Details
11.20.2 BioVision Business Overview
11.20.3 BioVision Epigenome Analysis Introduction
11.20.4 BioVision Revenue in Epigenome Analysis Business (2019-2024)
11.20.5 BioVision Recent Developments
11.21 Promega Corporation
11.21.1 Promega Corporation Company Details
11.21.2 Promega Corporation Business Overview
11.21.3 Promega Corporation Epigenome Analysis Introduction
11.21.4 Promega Corporation Revenue in Epigenome Analysis Business (2019-2024)
11.21.5 Promega Corporation Recent Developments
11.22 GeneTex
11.22.1 GeneTex Company Details
11.22.2 GeneTex Business Overview
11.22.3 GeneTex Epigenome Analysis Introduction
11.22.4 GeneTex Revenue in Epigenome Analysis Business (2019-2024)
11.22.5 GeneTex Recent Developments
11.23 Pacific Biosciences of California
11.23.1 Pacific Biosciences of California Company Details
11.23.2 Pacific Biosciences of California Business Overview
11.23.3 Pacific Biosciences of California Epigenome Analysis Introduction
11.23.4 Pacific Biosciences of California Revenue in Epigenome Analysis Business (2019-2024)
11.23.5 Pacific Biosciences of California Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Cellcentric
Syndax
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Enzo Life Sciences
EpiGentek Group
BioVision
Promega Corporation
GeneTex
Pacific Biosciences of California
听
听
*If Applicable.
